WELCOME TO THE PRACTITIONER EDUCATION CENTER
About the Endothelial Glycocalyx
Within the 60,000 miles of blood vessels in every human body, a structure invisible to the naked eye has widespread effects. The endothelial glycocalyx (EGX) is a micro-thin, gel-like lining that acts as gatekeeper, regulator, and much more for the blood vessels. The EGX is now recognized as a “novel biomarker” for vascular dysfunction.1
General practitioner and functional medicine expert Kristine Burke, MD, provides a primer on the latest research around vascular and endothelial function. She describes the endothelial glycocalyx (EGX) and how it affects every aspect of the endothelial structure.
Case Series: Plaque Regression
As a functional medicine practitioner, Kristine Burke, MD, serves many types of patients. She recently conducted a retrospective study to assess how EGX support changed plaque deposits and vascular age. She selected patients with stubborn plaque, which had been unresponsive to other interventions.
Cardiologist Dr. Joel Kahn evaluates current vascular biomarkers. Topics include Lp(a), precision medicine, 5 essential biomarkers, and more. Dr. Kahn also explores a case and its results, with a patient with erectile dysfunction. Identifying the key biomarkers for tracking vascular trajectory is an essential element of primary care.
The information on this webpage is for licensed healthcare practitioner education only, and is not to be disseminated to the general public.
1. Liew H, Roberts MA, MacGinley R, McMahon LP. Endothelial glycocalyx in health and kidney disease: Rising star or false Dawn?. Nephrology (Carlton). 2017;22(12):940-946. doi:10.1111/nep.13161